Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium on Exercise Tolerance in COPD with Pulmonary Rehabilitation
NCT00157235Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2002
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Sep 2002; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00157235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157235.